Bio-Techne announces a milestone of over 1,000 Ella systems in operation.

Minneapolis / PRNewswire / April 5, 2023 (local U.S. time)
Bio-Techne Corporation (NASDAQ:TECH) announced today that over 1,000 Ella automated immunoassay instruments are now operational, marking a significant milestone. This achievement reflects the growing demand across the scientific and clinical research sectors for rapid and efficient immunoassay solutions that can provide accurate and reliable biomarker analysis.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
Press Release Site